On December 30, 2021, Jim Sulat notified the board of directors of Arch Therapeutics, Inc. that he will resign as a member of the Board effective December 31, 2021. There are no disagreements of any kind between the Company and Mr. Sulat related to his resignation as a director or otherwise.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.14 USD | +9.62% | +9.62% | -84.25% |
1st Jan change | Capi. | |
---|---|---|
-84.25% | 4.62M | |
+11.14% | 127B | |
-5.10% | 11.32B | |
+4.02% | 9.04B | |
+37.56% | 5.56B | |
-24.06% | 4.72B | |
+8.55% | 3.45B | |
-6.94% | 2.86B | |
-5.85% | 2.07B | |
-11.84% | 2.04B |
- Stock Market
- Equities
- ARTH Stock
- News Arch Therapeutics, Inc.
- Arch Therapeutics, Inc. Announces Resignation of Jim Sulat as Member of the Board